Management and treatment of severe mental disorders in Henan Province

doi:10.12114/j.issn.1007-9572.2020.00.206

Abstract

Abstract: Background　As a major public health problem and a prominent social problem，the management and treatment of severe mental disorders emphasizes the comprehensive management of multiple departments and the integrated whole-process treatment of hospital and community.Studying the management and treatment status of registered patients with severe mental disorders may facilitate the improvement of healthcare delivery system，and may provide a basis for the recovery of patients' social function and reduction of disease burden.Objective　To analyze the management and treatment status of patients with severe mental disorders in Henan Province from 2014 to 2018，to provide supports for government departments to improve mental healthcare delivery system，develop treatment- and aid-related policies，and for the promotion of community rehabilitation services.Methods　The number of permanent residents in provincial cities，and counties（cities）directly administered by Henan provincial government stemmed from the data published by Chinese Center for Disease Control and Prevention.All patients with severe mental disorders in Henan Province registered in the information system between January 2014 and December 2018 were selected during January to April 2019.The usage of information system（coverage rate and the number of users），general information of registered patients，the registration，management and treatment of patients in 2018（ the number of permanent residents，registered patients，patients with standardized management，patients taking medicine regularly，stable patients，home-based management patients，reported prevalence，rates of standard management，regular medication and stability）were recorded.Prevalence rates of severe mental disorders，standard management，regular medication and stability in 2014 and 2018 were compared.The mean untreated period，mean course of disease and policy utilization of registered patients from 2014 to 2018 were analyzed.Results　By the end of 2018，174 counties / districts in Henan Province had opened user accounts of national information system，and input the information of the patients and provided follow-up services for them.The coverage rate of the system was 100.00% and the registered users numbered 3 429 in total.There were 413 240 registered patients in 2018，which increased by 66.54% compared with that（248 128）of 2014.In 2018，the reported prevalence rate of severe mental disorders was 4.34‰ for the whole province.The top three provincial cities with highest prevalence rate were Shangqiu（5.23‰），Zhoukou（5.23‰）and Zhumadian（5.23‰），and the top three counties（cities）directly administered by the provincial government with highest prevalence rate were Xincai（5.68‰），Lankao（5.17‰）and Huaxian（5.12‰）.In 2018，the rate of standard management of severe mental disorders was 72.99% for the whole province.The top one provincial city with highest rate of standard management was Luohe（87.96%），and the top one city（county）directly administered by the provincial government with highest rate of standard management was Lankao（96.08%）.The province owned a rate of regular medication of 30.31% in severe mental disorders patients in 2018.The top one provincial city and top one city（county）directly administered by the provincial government owning highest rate of regular medication were Luoyang（51.15%）and Dengzhou（74.95%），respectively.The province had a rate of stability of severe mental disorders of 81.43%.Jiyuan（97.76%）was the top one provincial city and Lankao（98.46%）was the top one city（county）directly administered by the provincial government owning highest rate of stability.Compared with 2014，in 2018，the province had higher reported prevalence rate of severe mental disorders，and higher rates of standard management，regular medication and stability，with growth rates of 66.92%，115.31%，80.10% and 62.44%，respectively（P<0.05）.The mean untreated period of patients with schizophrenia in the province showed a gradually shortened trend year by year from 2014 to 2018.In those with bipolar disorder and mental retardation（accompanied with mental disorders），the mean untreated period in 2015 was longer than that of 2014，then decreased annually during 2016—2018.For those with paranoid mental disorder associated with epilepsy，the mean untreated period decreased from 2014 to 2016，and then it was prolonged first and then shortened in the next two years.The mean untreated period of patients with schizoaffective disorder showed a gradually shortened trend year by year from 2014 to 2017，but the mean length of period in 2018 was consistent with that of 2017.For those with mental disorders associated with epilepsy，the mean untreated period decreased from 2014 to 2017，but the mean length of period in 2018 was slightly longer than that of 2017.The mean course for severe mental disorders（calculated based on the data of schizophrenia，which was selected as a representative disease）in the province from 2014 to 2018 was 13.45，12.12，10.66，10.50 and 10.10 years，respectively，with a trend of gradual decrease.Among the 2 500 cases receiving outpatient medical aids，1 629（65.16%）had subsistence allowance，631（25.24%）had benefits gained from the local federation of disabled persons，304（12.16%）had assistance from the local civil affairs departments，966（38.64%）had reimbursement for outpatient treatment of chronic diseases，and 346（13.84%）had at least 3 kinds of assistance derived from related policies.Conclusion　In Henan from 2014 to 2018，the number of registered patients with severe mental disorders increased gradually，the management and treatment status improved，and the untreated period shortened，with significant inter-area differences.The rate of regular medication needs to be improved further.

Key words: Mental disorders, Patient care management, Therapy, Status, Henan, Community mental health services, Information systems

摘要： 背景　严重精神障碍管理治疗作为重大的公共卫生问题和突出的社会问题，更强调多部门综合管理及医院-社区一体化的全程治疗。通过研究分析在册严重精神障碍患者的管理治疗现状，可健全服务体系，为恢复患者社会功能、减少疾病负担提供依据。目的　对2014—2018年河南省严重精神障碍患者管理治疗状况进行分析，以期为各级政府健全、完善精神卫生服务体系，制定救治救助政策及推进社区康复服务提供决策支持。方法　2019年1—4月选取2014年1月—2018年12月信息系统中河南省所有在册的严重精神障碍患者。2018年河南省各省辖市、省直管县（市）常住人口数来源于中国疾病预防控制中心公布数据。记录2018年信息系统使用情况（包括信息系统覆盖率、信息系统注册用户数）、在册患者一般资料、患者登记管理及治疗情况〔包括各省辖市、省直管县（市）常住人口数、在册患者数、规范管理患者数、规律服药患者数、病情稳定患者数、居家患者数、报告患病率、规范管理率、规律服药率、稳定率〕，比较2014年与2018年报告患病率、规范管理率、规律服药率、稳定率，记录2014—2018年在册患者未治期、病程，在册患者政策利用情况。结果　截至2018年底，河南省174个县/区全部开通信息系统用户账号，均开展患者信息录入随访工作，信息系统覆盖率为100.00%，系统注册总用户数为3 429例。2018年河南省在册患者共413 240例，对比2014年248 128例，环比增长66.54%。2018年河南省报告患病率平均为4.34‰，各省辖市中报告患病率前3位依次为商丘市（5.23‰）、周口市（5.23‰）、驻马店市（5.23‰）；省直管县（市）中报告患病率前3位依次为新蔡县（5.68‰）、兰考县（5.17‰）、滑县（5.12‰）。2018年河南省规范管理率平均为72.99%，各省辖市中漯河市规范管理率最高（87.96%）；省直管县（市）中兰考县规范管理率最高（96.08%）。2018年河南省规律服药率平均为30.31%，各省辖市中洛阳市规律服药率最高（51.15%）；省直管县（市）中邓州市规律服药率最高（74.95%）。2018年河南省稳定率平均为81.43%，各省辖市中济源市稳定率最高（97.76%）；各省直管县（市）中兰考县稳定率最高（98.46%）。与2014年相比，2018年河南省报告患病率、规范管理率、规律服药率、稳定率同比增长率分别为66.92%、115.31%、80.10%、62.44%。2018年河南省报告患病率、规范管理率、规律服药率、稳定率均高于2014年（P<0.05）。河南省精神分裂症在册患者的未治期2014—2018年逐年缩短；双相情感障碍、精神发育迟滞（伴发精神障碍）在册患者的未治期2015年较2014年有所延长，之后3年逐年缩短；偏执性精神病在册患者的未治期2014—2016年逐年缩短，之后2年先延长后缩短；分裂情感性精神障碍在册患者的未治期2014—2017年逐年缩短，2018年与2017年保持一致；癫痫所致精神障碍在册患者的未治期2014—2017年逐年缩短，2018年较2017年略有延长。以精神分裂症在册患者为标准，2014—2018年河南省在册患者病程分别为13.45、12.12、10.66、10.50、10.10年，逐年缩短。参加严重精神障碍门诊救助的2 500例患者中，享有低保救助者1 629例（65.16%），享有残联救助者631例（25.24%），享有民政救助者304例（12.16%），享有门诊慢性病报销者966例（38.64%），享有3种及以上救助政策者346例（13.84%）。结论　2014—2018年河南省严重精神障碍患者建档登记人数不断增多，患者管理和治疗状况有所提高，在册患者未治期有所缩短。但部分地市工作差距较大，规律服药率有待进一步提高。

关键词: 精神障碍, 病人医护管理, 治疗, 现状, 河南, 社区精神卫生服务, 信息系统

YAO Fengju,ZHANG Weiping,ZHANG Ruiling, et al. Management and treatment of severe mental disorders in Henan Province[J]. Chinese General Practice, 2020, 23(21): 2702-2708. DOI: 10.12114/j.issn.1007-9572.2020.00.206.
姚丰菊,张伟平,张瑞岭等. 河南省严重精神障碍患者管理治疗现状分析[J]. 中国全科医学, 2020, 23(21): 2702-2708. DOI: 10.12114/j.issn.1007-9572.2020.00.206.

References

［1］中华人民共和国精神卫生法［EB/OL］．（2012-10-26）［2019-08-04］．http：//www.gov.cn/jrzg/2012-10/26/content_2252122.htm. ［2］张宝霞，张佩佩.2016年天津市严重精神障碍患者现状及社区管理情况分析［J］．天津药学，2019，31（4）：62-66. ［3］徐斐斐，蒋霞，潘卫民，等．甘肃省严重精神障碍人群分布特征及现状［J］．疾病预防控制通报，2019，34（2）：15-17，55．DOI：10.13215/j.cnki.jbyfkztb.1810013. XU F F，JIANG X，PAN W M，et al．Distribution features and status of severe mental disorder in Gansu Province［J］．Bulletin of Disease Control and Prevention（China），2019，34（2）：15-17，55．DOI：10.13215/j.cnki.jbyfkztb.1810013. ［4］于欣，刘津，马弘.社区精神卫生——应对中国精神卫生挑战的 “抓手” ?［J］．中国心理卫生杂志，2010，24（12）：885-886，892．DOI：10.3969/j.issn.1000-6729.2010.12.001. YU X，LIU J，MA H.Community mental health：a panacea to confront the challenge in China?［J］．Chinese Mental Health Journal，2010，24（12）：885-886，892．DOI：10.3969/j.issn.1000-6729.2010.12.001. ［5］马弘，刘津，何燕玲，等．中国精神卫生服务模式改革的重要方向：686模式［J］．中国心理卫生杂志，2011，25（10）：725-728．DOI：10.3969/j.issn.1000-6729.2011.10.002. MA H，LIU J，HE Y L，et al．An important pathway of mental health service reform in China：introduction of 686 program［J］．Chinese Mental Health Journal，2011，25（10）：725-728．DOI：10.3969/j.issn.1000-6729.2011.10.002. ［6］卫生部办公厅关于启用国家重性精神疾病基本数据收集分析系统的通知［EB/OL］．（2011-08-16）［2018-08-04］．http：//www.nhc.gov.cn/zwgk/wtwj/201304/bd679875f52c4f46b86877e344acc8bd.shtml. ［7］王勋，马宁，王立英，等．2014年全国严重精神障碍患者管理信息分析［J］．中华精神科杂志，2016，49（3）：182-188．DOI：10.3760/cma.j.issn.1006-7884.2016.03.012. WANG X，MA N，WANG L Y，et al．Management and services for psychosis in People's Republic of China in 2014［J］．Chinese Journal of Psychiatry，2016，49（3）：182-188．DOI：10.3760/cma.j.issn.1006-7884.2016.03.012. ［8］关于印发严重精神障碍管理治疗工作规范（2018年版）的通知［EB/OL］．（2015-05-28）［2019-05-24］．http://www.nhc.gov.cn/xxgk/pages/viewdocument.jsp? dispatchDate=&staticUrl=/jkj/s7932/201806/90d5fe3b7f48453db9b9beb85dfdc8a8.shtml&wenhao=%E5%9B%BD%E5%8D%AB%E7%96%BE%E6%8E%A7%E5%8F%91%E3%80%942018%E3%80%9513%E5%8F%B7&utitle=%E5%85%B3%E4%BA%8E%E5%8D%B0%E5%8F%91%E4%B8%A5%E9%87%8D %E7%B2%BE%E7%A5%9E%E9%9A%9C%E7%A2%8D%E7%AE%A1%E7%90%86%E6%B2%BB%E7%96%97%E5%B7%A5%E4%BD%9C%E8%A7%84%E8%8C%83%EF%BC%882018%E5%B9%B4%E7%89%88%EF%BC%89%E7%9A%84%E9%80%9A%E7%9F%A5&topictype=&topic=&publishedOrg=%E7%96%BE %E7%97%85%E9%A2%84%E9%98%B2%E6%8E%A7%E5%88%B6%E5%B1%80&indexNum=000013610/2018-00174&manuscriptId=90d5fe3b7f48453db9b9beb85dfdc8a8. ［9］吴霞民，马宁，王立英，等．2015年全国严重精神障碍患者管理治疗现状分析［J］．中华精神科杂志，2017，50（4）：302-307．DOI：10.3760/cma.j.issn.1006-7884.2017.04.013. ［10］王勋，马宁，王立英，等．2016年全国严重精神障碍患者管理治疗现状分析［J］．中华精神科杂志，2018，51（1）：47-52．DOI：10.3760/cma.j.issn.1006-7884.2018.01.010. ［11］罗建军，蒋国庆，杨天翼.2016年重庆市严重精神障碍患者管理治疗信息分析［J］．精神医学杂志，2018，31（3）：200-204. LUO J J，JIANG G Q，YANG T Y.Information analysis for management and treatment in patients with severe mental disorders in Chongqing in 2016［J］．Journal of Psychiatry，2018，31（3）：200-204. ［12］国务院办公厅关于转发卫生计生委等部门全国精神卫生工作规划（2015—2020年）的通知［EB/OL］．（2015-06-04）［2018-08-04］．http：//www.gov.cn/zhengce/content/2015-06/18/content_9860.htm. ［13］张曼华，石扩，张婉奇，等．心理健康宣教对社区居民精神卫生知晓率的影响［J］．中国健康心理学杂志，2015，23（11）：1613-1616．DOI：10.13342/j.cnki.cjhp.2015.11.005. ZHANG M H，SHI K，ZHANG W Q，et al．Influence of psychological health education on mental health awareness in community residents［J］．China Journal of Health Psychology，2015，23（11）：1613-1616．DOI：10.13342/j.cnki.cjhp.2015.11.005. ［14］国家卫生计生委关于印发《国家基本公共卫生服务规范（第三版）》的通知［EB/OL］．（2017-03-28）［2019-08-04］．http：//www.nhc.gov.cn/jws/s3578/201703/d20c37e23e1f4c7db7b8e25f34473e1b.shtml. ［15］WANG X，ZHANG W，MA N，et al．Adherence to antipsychotic medication by community-based patients with schizophrenia in China：a cross-sectional study［J］．Psyehiatr Serv，2016，67（41）：431-437．DOI：10.1 1761appi.ps.201500056．［16］王勋，马宁，吴霞民，等．社区精神分裂症患者服药依从性及原因分析［J］．中国神经精神疾病杂志，2016，42（6）：374-378．DOI：10.3969/j.issn.1002-0152.2016.06.012. ［17］彭洪兴，高明泽.10省（区、市）医保目录收载治疗精神障碍药物类基本药物的情况分析［J］．中国药房，2017，28（3）：295-297．DOI：10.6039/j.issn.1001-0408.2017.03.02. PENG H X，GAO M Z.Analysis of antipsychotic essential medicines contained in health insurance directory in 10 provinces（autonomous regions or municipalities）［J］．China Pharmacy，2017，28（3）：295-297．DOI：10.6039/j.issn.1001- 0408.2017.03.02. ［18］康慧敏，管丽丽，王勋，等．“686项目”31个示范市（州）重性精神疾病患者经济水平及参保和治疗情况分析［J］．中国公共卫生，2015，31（8）：997-1001．DOI：10.11847/zgggws2015-31-08-06. KANG H M，GUAN L L，WANG X，et al．Economic condition，basic medical insurance and medication among patients with severe mental illness in 31 demonstration cities for “ 686 program” implementation［J］．Chinese Journal of Public Health ，2015，31（8）：997-1001．DOI：10.11847/zgggws2015-31-08-06. ［19］袁美英，戴涛，史俊研.患者病情与患者关系和照顾时间对精神病患者家属生活质量的影响［J］．中国药物与临床，2016，16（6）：866-868．DOI：10.11655/zgywylc2016.06.040. ［20］王继军，朱紫青，李春波，等．精神分裂症未治期及其影响因素研究［J］．上海精神医学，2009，21（1）：10-15．DOI：10.3969/j.issn.1002-0829.2009.01.003. WANG J J，ZHU Z Q，LI C B，et al．Duration of untreated illness and its influential factors in schizophrenia［J］．Shanghai Archives of Psychiatry，2009，21（1）：10-15．DOI：10.3969/j.issn.1002-0829.2009.01.003. ［21］QIN H Y，ZHANG J，WANG Z P，et al．Duration of untreated psychosis and clinical outcomes of first-episode schizophrenia：a 4-year follow-up study［J］．Shanghai Arch Psychiatry，2014，26（1）：42-48．DOI：10.3969/j.issn.1002-0829.2014.01.006. ［22］TABO A，AYDIN E，YUMRUK?AL H，et al．Longer duration of untreated psychosis hinders improvement in treatment of chronic schizophrenia：community based early intervention is an evidence based option［J］．Community Ment Health J，2017，53（8）：929-935．DOI：10.1007/s10597-017-0088-9. ［23］河南省人民政府办公厅转发省综治办等部门关于加强严重精神障碍患者救治救助工作实施意见的通知［EB/OL］．（2014-10-24）［2019-08-05］．https：//www.henan.gov.cn/2014/11-12/246610.html. ［24］河南省人民政府办公厅关于转发省卫生计生委等部门河南省精神卫生工作规划（2016—2020年）的通知［EB/OL］．（2016-03-25）［2019-08-05］．https：//www.henan.gov.cn/2016/04-18/247677.html. ［25］河南省22部门联合发文：《关于加强心理健康服务的实施意见》出台［EB/OL］．（2017-09-02）［2019-08-05］．https：//www.meipian.cn/rm2i1aq?from=timeline. ［26］河南省人力资源和社会保障厅河南省卫生和计划生育委员会关于进一步加强严重精神障碍门诊慢性病管理的通知（豫人社办〔2018〕140号）［EB/OL］．（2018-11-15）［2019-08-05］． http：//haly.si.gov.cn/synrgml/zhengcefagui/zhengcewenjian/yiliaobaoxian2/20181115113281215106.html. ［27］吴三兵，胡焱，辛昌茂，等．分级诊疗制度的实质与我国分级诊疗制度建设的出路［J］．中华医院管理杂志，2016，32（7）：485-487．DOI：10.3760/cma.j.issn.1000-6672.2016.07.002.

[1]	ZHANG Peng, LIU Lidi, ZHANG Ying, YANG Ziyu, LIU Changming, TANG Yijun, LIAO Xiaoyang, JIA Yu. Interpretation and Clinical Implications of the 2024 Italian Guidelines for the Management of Adult Individuals with Overweight and Obesity and Metabolic Comorbidities That are Resistant to Behavioral Treatment [J]. Chinese General Practice, 2025, 28(30): 3747-3752.
[2]	ZHU Chen, YU Jiawen, JIANG Hao, GAN Panpan, XIA Tian, XU Haitao, DU Yingying. Research on the Predictive Value of Lipid Characteristics about Digestive System Tumors for Normal Phase Angles [J]. Chinese General Practice, 2025, 28(27): 3385-3390.
[3]	ZHANG Tianyu, YU Haibo, CHEN Fei, LI Xin, ZHANG Jiajia, ZHAN Xiaokai, SHEN Man, TANG Ran, FAN Sibin, ZHAO Fengyi, HUANG Zhongxia. Meta-analysis of the Efficacy and Safety of Systemic Treatment for POEMS Syndrome [J]. Chinese General Practice, 2025, 28(27): 3447-3455.
[4]	CUI Yuyang, CHENG Guirong, ZENG Yan, HUANG Zhaolan, TAN Wei. Association between Marital Status, Social Support and Lifestyle with Cognitive Impairment among Community-dwelling Older Adults: Based on the Baseline Survey of Hubei Memory and Aging Cohort Study [J]. Chinese General Practice, 2025, 28(26): 3240-3247.
[5]	HUANG Yulin, WANG Haoyun, LI Yanmei, XIAO Xueying. Symptom Clusters in Gastric Cancer Patients Receiving Chemotherapy: a Scoping Review [J]. Chinese General Practice, 2025, 28(26): 3338-3344.
[6]	ZHI Congcong, LI Xue, CHENG Yicheng, WANG Xiaolong, ZHENG Lihua. Guidelines for Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Hemorrhoids (2025 Edition) [J]. Chinese General Practice, 2025, 28(26): 3217-3228.
[7]	WANG Yajing, DUAN Xiaoyang, HOU Ran, HUANG Yajie, SHI Jian. Advances in Targeted Combination Therapy for Patients with Brain Metastases from EGFR-mutated Non-small Cell Lung Cancer [J]. Chinese General Practice, 2025, 28(26): 3328-3337.
[8]	RUAN Wanbai, LI Junfeng, YIN Yanmei, PENG Lei, ZHU Kexiang. Research Progress of Targeted Therapy and Immunotherapy for Pancreatic Cancer [J]. Chinese General Practice, 2025, 28(23): 2950-2960.
[9]	YANG Handan, QIAO Wen, HE Shu, CHEN Yi, TONG Yunmei. The Impact of Acceptance and Commitment Therapy Combined with Sertraline on Depressive Mood, Suicidal Ideation, and Sleep Quality of Adolescents with Depression [J]. Chinese General Practice, 2025, 28(22): 2813-2818.
[10]	Chinese Geriatrics Society, General Practice Branch of Zhejiang Medical Association, the Expert Collaboration Group on Medically Unspecified Disease in General Practice. Expert Consensus on the Diagnosis, Treatment, and Management of Emaciation (2025) [J]. Chinese General Practice, 2025, 28(21): 2577-2594.
[11]	WANG Ying, YAN Yijun, LIU Lei, HU Yumin, ZHANG Yang, LIU Kai, JIANG Boren. Effects of Resistance Exercise Combined with Nutritional Intervention on Blood Glucose Stability in Elderly Patients with Type 2 Diabetes Mellitus with Sarcopenia [J]. Chinese General Practice, 2025, 28(21): 2604-2610.
[12]	YANG Jiang, LI Jiansheng, CHEN Yaolong, LIU Huiguo, WANG Jianxin, YU Jiajie, LI Huiru, XIAO Qionghua, XIE Yang, LI Suyun, WANG Minghang. Guideline on Treating Adult Community-acquired Pneumonia with Chinese Patent Medicines (2025 Edition) [J]. Chinese General Practice, 2025, 28(20): 2464-2480.
[13]	LUO Yunzhao, JIANG Hongchuan, XU Feng. Predicting Response to Neoadjuvant Therapy in Breast Cancer Using Deep Learning on Primary Core Needle Biopsy Slides [J]. Chinese General Practice, 2025, 28(19): 2407-2413.
[14]	GU Jie, HUANG Yanyan. Diagnosis and Comprehensive Management of Rare Diseases: the Indispensable Role of General Practitioners [J]. Chinese General Practice, 2025, 28(16): 1955-1960.
[15]	AN Qinyu, WANG Yiying, ZHANG Xiaodan, ZHANG Tianlin, ZHAN Qingqing, ZHANG Fuyan, LIU Tao, WU Yanli. Prospective Cohort Study of the Impact of Socioeconomic Status and Healthy Lifestyle on Cardiovascular Disease [J]. Chinese General Practice, 2025, 28(16): 2017-2024.